JPS6354684B2 - - Google Patents

Info

Publication number
JPS6354684B2
JPS6354684B2 JP59009910A JP991084A JPS6354684B2 JP S6354684 B2 JPS6354684 B2 JP S6354684B2 JP 59009910 A JP59009910 A JP 59009910A JP 991084 A JP991084 A JP 991084A JP S6354684 B2 JPS6354684 B2 JP S6354684B2
Authority
JP
Japan
Prior art keywords
liposome
drug
present
retaining
liposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP59009910A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60155109A (ja
Inventor
Haruo Honda
Tetsupei Maruyama
Noriko Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP991084A priority Critical patent/JPS60155109A/ja
Publication of JPS60155109A publication Critical patent/JPS60155109A/ja
Publication of JPS6354684B2 publication Critical patent/JPS6354684B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
JP991084A 1984-01-23 1984-01-23 リポソ−ム製剤 Granted JPS60155109A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP991084A JPS60155109A (ja) 1984-01-23 1984-01-23 リポソ−ム製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP991084A JPS60155109A (ja) 1984-01-23 1984-01-23 リポソ−ム製剤

Publications (2)

Publication Number Publication Date
JPS60155109A JPS60155109A (ja) 1985-08-15
JPS6354684B2 true JPS6354684B2 (enExample) 1988-10-28

Family

ID=11733259

Family Applications (1)

Application Number Title Priority Date Filing Date
JP991084A Granted JPS60155109A (ja) 1984-01-23 1984-01-23 リポソ−ム製剤

Country Status (1)

Country Link
JP (1) JPS60155109A (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
DE3542773A1 (de) * 1985-12-04 1987-06-11 Roehm Pharma Gmbh Hautwirksame pharmaka mit liposomen als wirkstofftraeger
JPS6396193A (ja) * 1986-10-14 1988-04-27 Saburo Senoo 新規なリポソーム
JPH01180245A (ja) * 1988-01-12 1989-07-18 Terumo Corp リポソーム
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
US5043164A (en) * 1989-01-17 1991-08-27 The University Of Tennessee Research Corporation Blood-stable, cholesterol-free liposomes
ATE135200T1 (de) * 1989-05-17 1996-03-15 Res Corp Technologies Inc Verfahren und zusammensetzung zur thrombosebehandlung beim säugetier
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
AU8061494A (en) * 1993-11-04 1995-05-23 Schering Aktiengesellschaft Charged liposome preparation
US5902604A (en) 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
WO2003015753A1 (fr) * 2001-08-20 2003-02-27 Terumo Kabushiki Kaisha Preparations de liposomes
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
WO2005123078A1 (ja) 2004-06-18 2005-12-29 Terumo Kabushiki Kaisha 水難溶性カンプトテシン含有リポソーム製剤
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
WO2014096165A2 (en) * 2012-12-21 2014-06-26 Bracco Suisse Sa Gas-filled microvesicles
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5287221A (en) * 1976-01-07 1977-07-20 Ajinomoto Co Inc Preventive for chicken dinfections
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees

Also Published As

Publication number Publication date
JPS60155109A (ja) 1985-08-15

Similar Documents

Publication Publication Date Title
JPS6354684B2 (enExample)
US4615885A (en) Pharmaceutical composition containing urokinase
US5665379A (en) Lipid particle forming matrix, preparation and use thereof
US5662931A (en) Process for preparing liposome composition
EP0591492B1 (en) A pharmaceutical composition containing a defined lipid system
US4544545A (en) Liposomes containing modified cholesterol for organ targeting
US4844904A (en) Liposome composition
EP0514506B1 (en) Lipid formulation system
JP3074733B2 (ja) 脂肪乳剤
JPS60231609A (ja) リポソ−ム製剤
EP0161445A1 (en) Water soluble drug complex and method for production of same
JPH0240644B2 (enExample)
PT726761E (pt) Composicoes farmaceuticas que microparticulas na forma de micelios
JP2844756B2 (ja) 脂肪乳剤
JPS6352010B2 (enExample)
JP2653245B2 (ja) 脂肪乳剤
JPS59222410A (ja) 薬物保持リポソ−ム製剤
JPWO2003015753A1 (ja) リポソーム製剤
JPWO1991007973A1 (ja) 脂肪乳剤
JPH0324452B2 (enExample)
JPH06183954A (ja) リポソーム製剤
JP3074732B2 (ja) 脂肪乳剤
JPH0651109B2 (ja) 脂質膜構造体
JP2911550B2 (ja) リポソーム製剤
JP3074731B2 (ja) 脂肪乳剤